0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hirudin Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-8X2673
Home | Market Reports | Health
COVID 19 Impact on Global Hirudin Market Insights Forecast to 2026
BUY CHAPTERS

Global Hirudin Market Research Report 2025

Code: QYRE-Auto-8X2673
Report
June 2025
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hirudin Market Size

The global market for Hirudin was valued at US$ 4223 million in the year 2024 and is projected to reach a revised size of US$ 5214 million by 2031, growing at a CAGR of 3.1% during the forecast period.

Hirudin Market

Hirudin Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hirudin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Hirudin is a potent anticoagulant protein originally derived from the salivary glands of the medicinal leech (Hirudo medicinalis). Its mechanism of action involves directly binding to thrombin, the enzyme responsible for converting fibrinogen into fibrin during the clotting process, thus preventing blood coagulation. This unique property makes hirudin a highly effective anticoagulant, especially in patients at risk of thrombus formation. With the advancement of biotechnology, the production of hirudin has shifted from being sourced directly from leeches to large-scale synthesis through recombinant DNA technology in laboratories. Currently, hirudin is primarily used in the treatment of thrombotic conditions such as deep vein thrombosis (DVT), pulmonary embolism, and certain types of strokes. It is considered an effective alternative for patients who are allergic or intolerant to traditional anticoagulants like heparin. Over the years, with increasing research into hirudin’s applications, various derivatives and related drugs, such as lepirudin and desirudin, have been developed, broadening its clinical use.
The market development of hirudin is driven by several factors. Firstly, the growing global demand for the treatment of thrombotic diseases, particularly among cardiovascular patients and post-surgical individuals, presents significant opportunities for hirudin and its derivatives. With the aging population and the increasing prevalence of thrombotic and vascular diseases, there is a rising demand for effective anticoagulants. Secondly, hirudin's unique mechanism of action offers advantages in treating certain conditions, particularly for patients who are allergic to traditional anticoagulants like heparin, further driving the market for hirudin products.
However, the hirudin market faces challenges and risks. The production cost remains high, particularly in the early stages when biotechnology was not fully developed, limiting its widespread use. Additionally, although hirudin has strong anticoagulant effects, its use requires careful monitoring of the patient's coagulation function to prevent the risk of bleeding.
In terms of market concentration, as production technologies for hirudin mature, the market has become more concentrated in the hands of a few large pharmaceutical companies that maintain their market share through acquisitions, research and development, and patented technologies. The downstream demand trend is diversifying, with hirudin finding applications not only in traditional thrombotic disease treatment but also in other coagulation disorders and post-surgical care. Recent technological advances include the recombinant production of hirudin using genetic engineering, which has significantly improved production efficiency and lowered costs, potentially expanding the use of hirudin in the future.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hirudin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hirudin.
The Hirudin market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hirudin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hirudin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hirudin Market Report

Report Metric Details
Report Name Hirudin Market
Accounted market size in year US$ 4223 million
Forecasted market size in 2031 US$ 5214 million
CAGR 3.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Teva Pharmaceuticals, Pfizer, Inc, Pentapharm, DUOPUTAI, Abbott, Keyken, Minapharm, Salubris Bio, Hoechst AG, Ciba-Geigy, Boehringer Ingelheim, Sanofi, Xellia Pharmaceuticals, Haplogen Pharmaceuticals, Shenzhen Kangtai Biological, Dong-A ST
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hirudin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Hirudin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Hirudin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Hirudin Market growing?

Ans: The Hirudin Market witnessing a CAGR of 3.1% during the forecast period 2025-2031.

What is the Hirudin Market size in 2031?

Ans: The Hirudin Market size in 2031 will be US$ 5214 million.

Who are the main players in the Hirudin Market report?

Ans: The main players in the Hirudin Market are Novartis, Teva Pharmaceuticals, Pfizer, Inc, Pentapharm, DUOPUTAI, Abbott, Keyken, Minapharm, Salubris Bio, Hoechst AG, Ciba-Geigy, Boehringer Ingelheim, Sanofi, Xellia Pharmaceuticals, Haplogen Pharmaceuticals, Shenzhen Kangtai Biological, Dong-A ST

What are the Application segmentation covered in the Hirudin Market report?

Ans: The Applications covered in the Hirudin Market report are Thrombosis Disease, Tumor Disease, Others

What are the Type segmentation covered in the Hirudin Market report?

Ans: The Types covered in the Hirudin Market report are Natural Hirudin, Recombinant Hirudin

Recommended Reports

Anticoagulant Drugs

Thrombosis Management

Blood Coagulation

1 Hirudin Market Overview
1.1 Product Definition
1.2 Hirudin by Type
1.2.1 Global Hirudin Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Natural Hirudin
1.2.3 Recombinant Hirudin
1.3 Hirudin by Application
1.3.1 Global Hirudin Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Thrombosis Disease
1.3.3 Tumor Disease
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Hirudin Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Hirudin Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Hirudin Production Estimates and Forecasts (2020-2031)
1.4.4 Global Hirudin Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Hirudin Production Market Share by Manufacturers (2020-2025)
2.2 Global Hirudin Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Hirudin, Industry Ranking, 2023 VS 2024
2.4 Global Hirudin Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Hirudin Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Hirudin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Hirudin, Product Offered and Application
2.8 Global Key Manufacturers of Hirudin, Date of Enter into This Industry
2.9 Hirudin Market Competitive Situation and Trends
2.9.1 Hirudin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Hirudin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Hirudin Production by Region
3.1 Global Hirudin Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Hirudin Production Value by Region (2020-2031)
3.2.1 Global Hirudin Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Hirudin by Region (2026-2031)
3.3 Global Hirudin Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Hirudin Production Volume by Region (2020-2031)
3.4.1 Global Hirudin Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Hirudin by Region (2026-2031)
3.5 Global Hirudin Market Price Analysis by Region (2020-2025)
3.6 Global Hirudin Production and Value, Year-over-Year Growth
3.6.1 North America Hirudin Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Hirudin Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Hirudin Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Hirudin Production Value Estimates and Forecasts (2020-2031)
4 Hirudin Consumption by Region
4.1 Global Hirudin Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Hirudin Consumption by Region (2020-2031)
4.2.1 Global Hirudin Consumption by Region (2020-2025)
4.2.2 Global Hirudin Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Hirudin Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Hirudin Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Hirudin Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Hirudin Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Hirudin Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Hirudin Production by Type (2020-2031)
5.1.1 Global Hirudin Production by Type (2020-2025)
5.1.2 Global Hirudin Production by Type (2026-2031)
5.1.3 Global Hirudin Production Market Share by Type (2020-2031)
5.2 Global Hirudin Production Value by Type (2020-2031)
5.2.1 Global Hirudin Production Value by Type (2020-2025)
5.2.2 Global Hirudin Production Value by Type (2026-2031)
5.2.3 Global Hirudin Production Value Market Share by Type (2020-2031)
5.3 Global Hirudin Price by Type (2020-2031)
6 Segment by Application
6.1 Global Hirudin Production by Application (2020-2031)
6.1.1 Global Hirudin Production by Application (2020-2025)
6.1.2 Global Hirudin Production by Application (2026-2031)
6.1.3 Global Hirudin Production Market Share by Application (2020-2031)
6.2 Global Hirudin Production Value by Application (2020-2031)
6.2.1 Global Hirudin Production Value by Application (2020-2025)
6.2.2 Global Hirudin Production Value by Application (2026-2031)
6.2.3 Global Hirudin Production Value Market Share by Application (2020-2031)
6.3 Global Hirudin Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Novartis
7.1.1 Novartis Hirudin Company Information
7.1.2 Novartis Hirudin Product Portfolio
7.1.3 Novartis Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Novartis Main Business and Markets Served
7.1.5 Novartis Recent Developments/Updates
7.2 Teva Pharmaceuticals
7.2.1 Teva Pharmaceuticals Hirudin Company Information
7.2.2 Teva Pharmaceuticals Hirudin Product Portfolio
7.2.3 Teva Pharmaceuticals Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Teva Pharmaceuticals Main Business and Markets Served
7.2.5 Teva Pharmaceuticals Recent Developments/Updates
7.3 Pfizer, Inc
7.3.1 Pfizer, Inc Hirudin Company Information
7.3.2 Pfizer, Inc Hirudin Product Portfolio
7.3.3 Pfizer, Inc Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Pfizer, Inc Main Business and Markets Served
7.3.5 Pfizer, Inc Recent Developments/Updates
7.4 Pentapharm
7.4.1 Pentapharm Hirudin Company Information
7.4.2 Pentapharm Hirudin Product Portfolio
7.4.3 Pentapharm Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Pentapharm Main Business and Markets Served
7.4.5 Pentapharm Recent Developments/Updates
7.5 DUOPUTAI
7.5.1 DUOPUTAI Hirudin Company Information
7.5.2 DUOPUTAI Hirudin Product Portfolio
7.5.3 DUOPUTAI Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.5.4 DUOPUTAI Main Business and Markets Served
7.5.5 DUOPUTAI Recent Developments/Updates
7.6 Abbott
7.6.1 Abbott Hirudin Company Information
7.6.2 Abbott Hirudin Product Portfolio
7.6.3 Abbott Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Abbott Main Business and Markets Served
7.6.5 Abbott Recent Developments/Updates
7.7 Keyken
7.7.1 Keyken Hirudin Company Information
7.7.2 Keyken Hirudin Product Portfolio
7.7.3 Keyken Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Keyken Main Business and Markets Served
7.7.5 Keyken Recent Developments/Updates
7.8 Minapharm
7.8.1 Minapharm Hirudin Company Information
7.8.2 Minapharm Hirudin Product Portfolio
7.8.3 Minapharm Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Minapharm Main Business and Markets Served
7.8.5 Minapharm Recent Developments/Updates
7.9 Salubris Bio
7.9.1 Salubris Bio Hirudin Company Information
7.9.2 Salubris Bio Hirudin Product Portfolio
7.9.3 Salubris Bio Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Salubris Bio Main Business and Markets Served
7.9.5 Salubris Bio Recent Developments/Updates
7.10 Hoechst AG
7.10.1 Hoechst AG Hirudin Company Information
7.10.2 Hoechst AG Hirudin Product Portfolio
7.10.3 Hoechst AG Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Hoechst AG Main Business and Markets Served
7.10.5 Hoechst AG Recent Developments/Updates
7.11 Ciba-Geigy
7.11.1 Ciba-Geigy Hirudin Company Information
7.11.2 Ciba-Geigy Hirudin Product Portfolio
7.11.3 Ciba-Geigy Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Ciba-Geigy Main Business and Markets Served
7.11.5 Ciba-Geigy Recent Developments/Updates
7.12 Boehringer Ingelheim
7.12.1 Boehringer Ingelheim Hirudin Company Information
7.12.2 Boehringer Ingelheim Hirudin Product Portfolio
7.12.3 Boehringer Ingelheim Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Boehringer Ingelheim Main Business and Markets Served
7.12.5 Boehringer Ingelheim Recent Developments/Updates
7.13 Sanofi
7.13.1 Sanofi Hirudin Company Information
7.13.2 Sanofi Hirudin Product Portfolio
7.13.3 Sanofi Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Sanofi Main Business and Markets Served
7.13.5 Sanofi Recent Developments/Updates
7.14 Xellia Pharmaceuticals
7.14.1 Xellia Pharmaceuticals Hirudin Company Information
7.14.2 Xellia Pharmaceuticals Hirudin Product Portfolio
7.14.3 Xellia Pharmaceuticals Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Xellia Pharmaceuticals Main Business and Markets Served
7.14.5 Xellia Pharmaceuticals Recent Developments/Updates
7.15 Haplogen Pharmaceuticals
7.15.1 Haplogen Pharmaceuticals Hirudin Company Information
7.15.2 Haplogen Pharmaceuticals Hirudin Product Portfolio
7.15.3 Haplogen Pharmaceuticals Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Haplogen Pharmaceuticals Main Business and Markets Served
7.15.5 Haplogen Pharmaceuticals Recent Developments/Updates
7.16 Shenzhen Kangtai Biological
7.16.1 Shenzhen Kangtai Biological Hirudin Company Information
7.16.2 Shenzhen Kangtai Biological Hirudin Product Portfolio
7.16.3 Shenzhen Kangtai Biological Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.16.4 Shenzhen Kangtai Biological Main Business and Markets Served
7.16.5 Shenzhen Kangtai Biological Recent Developments/Updates
7.17 Dong-A ST
7.17.1 Dong-A ST Hirudin Company Information
7.17.2 Dong-A ST Hirudin Product Portfolio
7.17.3 Dong-A ST Hirudin Production, Value, Price and Gross Margin (2020-2025)
7.17.4 Dong-A ST Main Business and Markets Served
7.17.5 Dong-A ST Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Hirudin Industry Chain Analysis
8.2 Hirudin Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Hirudin Production Mode & Process Analysis
8.4 Hirudin Sales and Marketing
8.4.1 Hirudin Sales Channels
8.4.2 Hirudin Distributors
8.5 Hirudin Customer Analysis
9 Hirudin Market Dynamics
9.1 Hirudin Industry Trends
9.2 Hirudin Market Drivers
9.3 Hirudin Market Challenges
9.4 Hirudin Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Hirudin Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Hirudin Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Hirudin Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Hirudin Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Hirudin Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Hirudin Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Hirudin Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Hirudin, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Hirudin as of 2024)
 Table 10. Global Market Hirudin Average Price by Manufacturers (US$/kg) & (2020-2025)
 Table 11. Global Key Manufacturers of Hirudin, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Hirudin, Product Offered and Application
 Table 13. Global Key Manufacturers of Hirudin, Date of Enter into This Industry
 Table 14. Global Hirudin Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hirudin Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Hirudin Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Hirudin Production Value Market Share by Region (2020-2025)
 Table 19. Global Hirudin Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Hirudin Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Hirudin Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Hirudin Production (Tons) by Region (2020-2025)
 Table 23. Global Hirudin Production Market Share by Region (2020-2025)
 Table 24. Global Hirudin Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Hirudin Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Hirudin Market Average Price (US$/kg) by Region (2020-2025)
 Table 27. Global Hirudin Market Average Price (US$/kg) by Region (2026-2031)
 Table 28. Global Hirudin Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Hirudin Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Hirudin Consumption Market Share by Region (2020-2025)
 Table 31. Global Hirudin Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Hirudin Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Hirudin Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Hirudin Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Hirudin Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Hirudin Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Hirudin Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Hirudin Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Hirudin Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Hirudin Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Hirudin Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Hirudin Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Hirudin Production (Tons) by Type (2020-2025)
 Table 46. Global Hirudin Production (Tons) by Type (2026-2031)
 Table 47. Global Hirudin Production Market Share by Type (2020-2025)
 Table 48. Global Hirudin Production Market Share by Type (2026-2031)
 Table 49. Global Hirudin Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Hirudin Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Hirudin Production Value Market Share by Type (2020-2025)
 Table 52. Global Hirudin Production Value Market Share by Type (2026-2031)
 Table 53. Global Hirudin Price (US$/kg) by Type (2020-2025)
 Table 54. Global Hirudin Price (US$/kg) by Type (2026-2031)
 Table 55. Global Hirudin Production (Tons) by Application (2020-2025)
 Table 56. Global Hirudin Production (Tons) by Application (2026-2031)
 Table 57. Global Hirudin Production Market Share by Application (2020-2025)
 Table 58. Global Hirudin Production Market Share by Application (2026-2031)
 Table 59. Global Hirudin Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Hirudin Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Hirudin Production Value Market Share by Application (2020-2025)
 Table 62. Global Hirudin Production Value Market Share by Application (2026-2031)
 Table 63. Global Hirudin Price (US$/kg) by Application (2020-2025)
 Table 64. Global Hirudin Price (US$/kg) by Application (2026-2031)
 Table 65. Novartis Hirudin Company Information
 Table 66. Novartis Hirudin Specification and Application
 Table 67. Novartis Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 68. Novartis Main Business and Markets Served
 Table 69. Novartis Recent Developments/Updates
 Table 70. Teva Pharmaceuticals Hirudin Company Information
 Table 71. Teva Pharmaceuticals Hirudin Specification and Application
 Table 72. Teva Pharmaceuticals Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 73. Teva Pharmaceuticals Main Business and Markets Served
 Table 74. Teva Pharmaceuticals Recent Developments/Updates
 Table 75. Pfizer, Inc Hirudin Company Information
 Table 76. Pfizer, Inc Hirudin Specification and Application
 Table 77. Pfizer, Inc Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 78. Pfizer, Inc Main Business and Markets Served
 Table 79. Pfizer, Inc Recent Developments/Updates
 Table 80. Pentapharm Hirudin Company Information
 Table 81. Pentapharm Hirudin Specification and Application
 Table 82. Pentapharm Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 83. Pentapharm Main Business and Markets Served
 Table 84. Pentapharm Recent Developments/Updates
 Table 85. DUOPUTAI Hirudin Company Information
 Table 86. DUOPUTAI Hirudin Specification and Application
 Table 87. DUOPUTAI Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 88. DUOPUTAI Main Business and Markets Served
 Table 89. DUOPUTAI Recent Developments/Updates
 Table 90. Abbott Hirudin Company Information
 Table 91. Abbott Hirudin Specification and Application
 Table 92. Abbott Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. Abbott Main Business and Markets Served
 Table 94. Abbott Recent Developments/Updates
 Table 95. Keyken Hirudin Company Information
 Table 96. Keyken Hirudin Specification and Application
 Table 97. Keyken Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 98. Keyken Main Business and Markets Served
 Table 99. Keyken Recent Developments/Updates
 Table 100. Minapharm Hirudin Company Information
 Table 101. Minapharm Hirudin Specification and Application
 Table 102. Minapharm Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 103. Minapharm Main Business and Markets Served
 Table 104. Minapharm Recent Developments/Updates
 Table 105. Salubris Bio Hirudin Company Information
 Table 106. Salubris Bio Hirudin Specification and Application
 Table 107. Salubris Bio Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 108. Salubris Bio Main Business and Markets Served
 Table 109. Salubris Bio Recent Developments/Updates
 Table 110. Hoechst AG Hirudin Company Information
 Table 111. Hoechst AG Hirudin Specification and Application
 Table 112. Hoechst AG Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 113. Hoechst AG Main Business and Markets Served
 Table 114. Hoechst AG Recent Developments/Updates
 Table 115. Ciba-Geigy Hirudin Company Information
 Table 116. Ciba-Geigy Hirudin Specification and Application
 Table 117. Ciba-Geigy Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 118. Ciba-Geigy Main Business and Markets Served
 Table 119. Ciba-Geigy Recent Developments/Updates
 Table 120. Boehringer Ingelheim Hirudin Company Information
 Table 121. Boehringer Ingelheim Hirudin Specification and Application
 Table 122. Boehringer Ingelheim Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 123. Boehringer Ingelheim Main Business and Markets Served
 Table 124. Boehringer Ingelheim Recent Developments/Updates
 Table 125. Sanofi Hirudin Company Information
 Table 126. Sanofi Hirudin Specification and Application
 Table 127. Sanofi Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 128. Sanofi Main Business and Markets Served
 Table 129. Sanofi Recent Developments/Updates
 Table 130. Xellia Pharmaceuticals Hirudin Company Information
 Table 131. Xellia Pharmaceuticals Hirudin Specification and Application
 Table 132. Xellia Pharmaceuticals Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 133. Xellia Pharmaceuticals Main Business and Markets Served
 Table 134. Xellia Pharmaceuticals Recent Developments/Updates
 Table 135. Haplogen Pharmaceuticals Hirudin Company Information
 Table 136. Haplogen Pharmaceuticals Hirudin Specification and Application
 Table 137. Haplogen Pharmaceuticals Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 138. Haplogen Pharmaceuticals Main Business and Markets Served
 Table 139. Haplogen Pharmaceuticals Recent Developments/Updates
 Table 140. Shenzhen Kangtai Biological Hirudin Company Information
 Table 141. Shenzhen Kangtai Biological Hirudin Specification and Application
 Table 142. Shenzhen Kangtai Biological Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 143. Shenzhen Kangtai Biological Main Business and Markets Served
 Table 144. Shenzhen Kangtai Biological Recent Developments/Updates
 Table 145. Dong-A ST Hirudin Company Information
 Table 146. Dong-A ST Hirudin Specification and Application
 Table 147. Dong-A ST Hirudin Production (Tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 148. Dong-A ST Main Business and Markets Served
 Table 149. Dong-A ST Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Hirudin Distributors List
 Table 153. Hirudin Customers List
 Table 154. Hirudin Market Trends
 Table 155. Hirudin Market Drivers
 Table 156. Hirudin Market Challenges
 Table 157. Hirudin Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hirudin
 Figure 2. Global Hirudin Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Hirudin Market Share by Type: 2024 VS 2031
 Figure 4. Natural Hirudin Product Picture
 Figure 5. Recombinant Hirudin Product Picture
 Figure 6. Global Hirudin Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Hirudin Market Share by Application: 2024 VS 2031
 Figure 8. Thrombosis Disease
 Figure 9. Tumor Disease
 Figure 10. Others
 Figure 11. Global Hirudin Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Hirudin Production Value (US$ Million) & (2020-2031)
 Figure 13. Global Hirudin Production Capacity (Tons) & (2020-2031)
 Figure 14. Global Hirudin Production (Tons) & (2020-2031)
 Figure 15. Global Hirudin Average Price (US$/kg) & (2020-2031)
 Figure 16. Hirudin Report Years Considered
 Figure 17. Hirudin Production Share by Manufacturers in 2024
 Figure 18. Global Hirudin Production Value Share by Manufacturers (2024)
 Figure 19. Hirudin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. The Global 5 and 10 Largest Players: Market Share by Hirudin Revenue in 2024
 Figure 21. Global Hirudin Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 22. Global Hirudin Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 23. Global Hirudin Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 24. Global Hirudin Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 25. North America Hirudin Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 26. Europe Hirudin Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. China Hirudin Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. Japan Hirudin Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Global Hirudin Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 30. Global Hirudin Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 31. North America Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 32. North America Hirudin Consumption Market Share by Country (2020-2031)
 Figure 33. U.S. Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 34. Canada Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Europe Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 36. Europe Hirudin Consumption Market Share by Country (2020-2031)
 Figure 37. Germany Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 38. France Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. U.K. Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. Italy Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Russia Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Asia Pacific Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. Asia Pacific Hirudin Consumption Market Share by Region (2020-2031)
 Figure 44. China Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 45. Japan Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. South Korea Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. China Taiwan Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. Southeast Asia Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. India Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. Latin America, Middle East & Africa Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. Latin America, Middle East & Africa Hirudin Consumption Market Share by Country (2020-2031)
 Figure 52. Mexico Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 53. Brazil Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. Turkey Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. GCC Countries Hirudin Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 56. Global Production Market Share of Hirudin by Type (2020-2031)
 Figure 57. Global Production Value Market Share of Hirudin by Type (2020-2031)
 Figure 58. Global Hirudin Price (US$/kg) by Type (2020-2031)
 Figure 59. Global Production Market Share of Hirudin by Application (2020-2031)
 Figure 60. Global Production Value Market Share of Hirudin by Application (2020-2031)
 Figure 61. Global Hirudin Price (US$/kg) by Application (2020-2031)
 Figure 62. Hirudin Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

RELATED REPORTS

Global Clavicle Brace Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0P17042
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Drug-Free Pain Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33I16356
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Drawer Freezer Rack Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17F16823
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Manual Bobath Table Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20X16760
Thu Sep 25 00:00:00 UTC 2025

Add to Cart